Will These 5 Drug Bigwigs Surpass Q3 Earnings Forecasts?
Yahoo Finance · Nov 2, 2026 · Novo Nordisk A S (NVO)
AMGN, PFE, MRNA, NVO and VTRS are set to report this week as recent beats and key drug demand set up a pivotal Q3 earnings test for pharma giants.
Not investment advice. Headline and summary only, not a full reprint.